Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir

Clinical and molecular hepatology

Volumn 20, Issue 3, 2014, Pages 267-273

  Ze, EunYoung ^a   Baek, Eun K yung ^a   Lee, Jong J in ^a   Chung, Han W ook ^a   Ahn, Dae G eon ^a   Cho, Hwan J un ^a   Kwon, Jae C heol ^a   Kim, Hyung J oon ^a   Lee, HyunWoong ^a  

^a Chung Ang University College of Medicine   (South Korea)

Author keywords

Adefovir; Chronic hepatitis B; Entecavir; Lamivudine; Resistance

Indexed keywords

ADEFOVIR; ADENINE; ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; ENTECAVIR; GUANINE; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; PHOSPHONIC ACID DERIVATIVE; VIRUS DNA;

ADULT; AGED; ANALOGS AND DERIVATIVES; ANTIVIRAL RESISTANCE; BLOOD; DRUG COMBINATION; FEMALE; GENETICS; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VIROLOGY;

ADENINE; ADULT; AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; DNA, VIRAL; DRUG RESISTANCE, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; GUANINE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MALE; MIDDLE AGED; ORGANOPHOSPHONATES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84932104604     PISSN: None     EISSN: 2287285X     Source Type: Journal    
DOI: 10.3350/cmh.2014.20.3.267     Document Type: Article

References (0)